Omeprazole

CAS 73590-58-6 32 current records 6 historicalSmall Molecule

Who holds supplier records for Omeprazole? 32 organisations hold a current record for Omeprazole: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 25 of them hold a valid EU Certificate of Suitability (26 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (19), China (3), Spain (2), Netherlands (1) and 3 other countries (3); not recorded for 4.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Omeprazole: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/omeprazole

Reading the evidence

  • 32 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    19 of the 28 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 19 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Omeprazole expires 8 Dec 2036. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (32)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Omeprazole. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • Dr. Reddy's Laboratories Ltd.
    Active DMF 12917, 24640, 19713 · latest filing Feb 2011
    IndiaCEP Company GMP cert on record
  • Cipla Limited
    Active DMF 40894, 12827 · latest filing Dec 2024
    IndiaCEP Company GMP cert on record
  • Hetero Drugs Limited
    Active DMF 25712, 15024 · latest filing Jan 2012
    IndiaCEP Company GMP cert on record
  • SHOUGUANG FUKANG PHARMACEUTICAL CO LTD
    Active DMF 22897, 24923 · latest filing May 2011
    ChinaCEP Company GMP cert on record
  • APITORIA PHARMA PRIVATE LTD
    Active DMF 21223 · latest filing Dec 2007
    IndiaCEP Company GMP cert on record
  • CHROMO LABORATORIES INDIA PRIVATE LTD
    Active DMF 38586 · latest filing Apr 2024
    IndiaCEP
  • ESTEVE QUIMICA SA
    Active DMF 11794, 11017 · latest filing Dec 1995
    CEP Company GMP cert on record
  • Granules India Limited
    Active DMF 37449 · latest filing Sept 2022
    IndiaCEP Company GMP cert on record
  • LEE PHARMA LTD
    Active DMF 37921 · latest filing May 2023
    IndiaCEP Company GMP cert on record
  • METROCHEM API PRIVATE LTD
    Active DMF 27928, 34759 · latest filing Jun 2020
    IndiaCEP
  • Natco Pharma
    Active DMF 21310 · latest filing Feb 2008
    IndiaCEP Company GMP cert on record
  • QUIMICA SINTETICA SA
    Active DMF 12605 · latest filing Jul 1997
    SpainCEP Company GMP cert on record
  • SRINI PHARMACEUTICALS PRIVATE LIMITED
    Active DMF 22471 · latest filing Jan 2009
    IndiaCEP Company GMP cert on record
  • TAPI NL BV
    Active DMF 25621 · latest filing Dec 2011
    NetherlandsCEP
  • UNION QUIMICO FARMACEUTICA SA (UQUIFA SA)
    Active DMF 11551, 15804, 17255 · latest filing Mar 2004
    SpainCEP
  • ZHEJIANG JINHUA CONBA BIO-PHARM CO LTD
    Active DMF 24118 · latest filing Sept 2010
    ChinaCEP Company GMP cert on record
  • Zydus Lifesciences Limited
    Active DMF 21793 · latest filing Jul 2008
    IndiaCEP Company GMP cert on record
  • ALIVUS LIFE SCIENCES LTD
    Active DMF 29633 · latest filing Oct 2015
    India Company GMP cert on record
  • Everest Organics Limited
    Active DMF 37155 · latest filing May 2022
    India
  • Lupin Limited
    Active DMF 21498 · latest filing Mar 2008
    India Company GMP cert on record
  • RAKS PHARMA PVT LTD
    Active DMF 29402 · latest filing Jun 2015
    India
  • SRI SAI CHANDANA API PRIVATE LIMITED
    Active DMF 44233 · latest filing Jul 2026
    India
  • Sun Pharmaceutical Industries Limited
    Active DMF 26796 · latest filing Mar 2013
    India Company GMP cert on record
  • YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTD
    Active DMF 28310 · latest filing Jul 2014
  • SwedenCEP Company GMP cert on record
  • NOSCH LABS PRIVATE LTD
    CEP Company GMP cert on record
  • SCINOPHARM TAIWAN LTD
    Inactive DMF 17392, 15949 · latest filing May 2004
    TaiwanCEP
  • IndiaCEP
  • Teva Pharmaceutical Industries Ltd.
    IsraelCEP Company GMP cert on record
  • ULKAR KIMYA SANAYII VE TICARET AS
    CEP
  • Zhejiang Huayi Pharmaceutical Co., Ltd.
    ChinaCEP
  • SRISAICHANDANA API PRIVATE LIMITED
    Valid CEP holder (EDQM); not necessarily the manufacturer
    IndiaCEP
Need Omeprazole sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (26)

Certificates of Suitability on the EDQM register for Omeprazole, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 41 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SRISAICHANDANA API PRIVATE LIMITED Anakapalli DistrictIN
CEP 2024-472 - Rev 00
Omeprazole
Jun 2026—
CIPLA LIMITED MumbaiIN
CEP 1997-122 - Rev 07
Omeprazole
Jun 2026—
ESTEVE QUIMICA S.A. BarcelonaES
CEP 1998-145 - Rev 12
Omeprazole, Micronised and sieved grade
Feb 2026—
ZHEJIANG JINHUA CONBA BIO-PHARM. CO., LTD. Jinhua CityCN
CEP 2016-109 - Rev 02
Omeprazole
Jan 2026—
NOSCH LABS PRIVATE LIMITED HyderabadIN
CEP 2019-339 - Rev 01
Omeprazole
Nov 2025—
GRANULES INDIA LIMITED HyderabadIN
CEP 2022-406 - Rev 01
Omeprazole
Aug 2025—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2011-228 - Rev 03
Omeprazole, Process II
Aug 2025—
LEE PHARMA LIMITED HyderabadIN
CEP 2007-006 - Rev 05
Omeprazole, Micronised
Jul 2025—
HETERO DRUGS LIMITED HyderabadIN
CEP 2015-011 - Rev 03
Omeprazole, Form-B
May 2025—
TAPI NL B.V. AmsterdamNL
CEP 2011-065 - Rev 03
Omeprazole, Alternative process
Jan 2025—
CHROMO LABORATORIES INDIA PRIVATE LIMITED PashamylaramIN
CEP 2023-238 - Rev 00
Omeprazole
Oct 2024—
METROCHEM API PRIVATE LIMITED HyderabadIN
CEP 2020-182 - Rev 01
Omeprazole
Jul 2024—
SHOUGUANG FUKANG PHARMACEUTICAL CO., LTD. Shouguang CityCN
CEP 2011-237 - Rev 01
Omeprazole, Process B
Jun 2024—
ZHEJIANG HUAYI PHARMACEUTICAL CO., LTD. YiwuCN
CEP 2012-326 - Rev 01
Omeprazole
Jan 2024—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2008-075 - Rev 05
Omeprazole
Jan 2024—
Union Quimico Farmaceutica, S.A. (Uquifa S.A.) BarcelonaES
R0-CEP 2022-120 - Rev 00
Omeprazole, Site II - Micronised and sieved grade
Sept 2022—
ZYDUS LIFESCIENCES LIMITED VadodaraIN
R1-CEP 2011-162 - Rev 02
Omeprazole, Process II
Jul 2022—
ZYDUS LIFESCIENCES LIMITED VadodaraIN
R1-CEP 2003-102 - Rev 03
Omeprazole
Jul 2022—
SRINI PHARMACEUTICALS PRIVATE LIMITED ChoutuppalIN
R1-CEP 2015-003 - Rev 00
Omeprazole
Dec 2021—
ASTRAZENECA AB SödertäljeSE
R1-CEP 2000-125 - Rev 06
Omeprazole
Oct 2020—
QUIMICA SINTETICA S.A. Alcala De HenaresES
R1-CEP 1999-093 - Rev 08
Omeprazole
Feb 2019—
NATCO PHARMA LIMITED HyderabadIN
R1-CEP 2007-148 - Rev 02
Omeprazole
Feb 2017—
SMILAX LABORATORIES LIMITED HyderabadIN
R1-CEP 2009-052 - Rev 00
Omeprazole
Sept 2015—
SCINOPHARM TAIWAN LTD. Shan-HuaTW
R1-CEP 2003-268 - Rev 03
Omeprazole
Apr 2013—
Teva Pharmaceutical Industries Ltd. Petach TikvaIL
R1-CEP 2002-112 - Rev 03
Omeprazole
Mar 2013—
Ulkar Kimya Sanayii Ve Ticaret Anonim Sirketi UmraniyeTR
R1-CEP 2000-157 - Rev 03
Omeprazole
Feb 2013—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (6)

Organisations whose Type II DMFs for Omeprazole are no longer active. These show a past filing, not current supply.

Show all 6 historical records

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (53 listed products contain Omeprazole). The latest listed patent expires 8 Dec 2036. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Omeprazole is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1503).

Chemical identity

IUPAC name
6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole
Canonical SMILES
CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC
InChIKey
SUBDBMMJDZJVOS-UHFFFAOYSA-N
Synonyms
Antra, H 168/68, H-168/68, Losec, Losec mups, Mezzopram, Mopral, NSC-751450, NSC-759192, Omeprazol, Omeprazole, Omeprazole component of konvomep

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Proton Pump Inhibitor
Mechanism of action
Cytochrome P450 2C19 Inhibitors; Proton Pump Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Omeprazole?

32 organisations hold an active US FDA Type II Drug Master File or a CEP for Omeprazole: Dr. Reddy's Laboratories Ltd. (India), Cipla Limited (India), Hetero Drugs Limited (India), SHOUGUANG FUKANG PHARMACEUTICAL CO LTD (China), APITORIA PHARMA PRIVATE LTD (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India), ESTEVE QUIMICA SA and Granules India Limited (India), and 24 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Omeprazole Drug Master Files are active?

Dr. Reddy's Laboratories Ltd. (DMF 12917, 24640), Cipla Limited (DMF 40894, 12827), Hetero Drugs Limited (DMF 25712, 15024), SHOUGUANG FUKANG PHARMACEUTICAL CO LTD (DMF 22897, 24923), APITORIA PHARMA PRIVATE LTD (DMF 21223), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 38586), ESTEVE QUIMICA SA (DMF 11794, 11017) and Granules India Limited (DMF 37449) and 16 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Omeprazole records mean?

6 organisations have only inactive Type II DMFs for Omeprazole. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Omeprazole have a European Certificate of Suitability?

Yes. 25 organisations hold a valid CEP for Omeprazole on the EDQM register, including SRISAICHANDANA API PRIVATE LIMITED Anakapalli District (IN), CIPLA LIMITED Mumbai (IN), ESTEVE QUIMICA S.A. Barcelona (ES), ZHEJIANG JINHUA CONBA BIO-PHARM. CO., LTD. Jinhua City (CN), NOSCH LABS PRIVATE LIMITED Hyderabad (IN) and GRANULES INDIA LIMITED Hyderabad (IN) and 20 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Omeprazole?

Yes. The latest patent listed for an approved US product containing Omeprazole expires 8 Dec 2036, across 53 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Omeprazole supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Omeprazole?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.